GRPR and pancreatic neoplasm: The amide-to-triazole switch was reported on the minimal binding sequence of bombesin BBN(7-14), an agonistic ligand of the gastrin-releasing peptide receptor (GRPR), which is overexpressed in a variety of tumours (i.e., prostate, breast, lung and pancreatic cancer) [77].